OmniAb
OABI
NASDAQ
IPO2022
about OABI
OmniAb discovers, develops, and produces innovative therapeutic proteins, including monoclonal antibodies, for the treatment of various diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $1.77 | $1.82 | $1.72 | $249.04M | 308.68K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.14 | n/a | 92.74 | -810.18% | -738.05% | 0% |